12-19439811-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_153207.5(AEBP2):c.112G>A(p.Glu38Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000464 in 1,510,212 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153207.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AEBP2 | NM_153207.5 | c.112G>A | p.Glu38Lys | missense_variant | 1/8 | ENST00000266508.14 | NP_694939.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AEBP2 | ENST00000266508.14 | c.112G>A | p.Glu38Lys | missense_variant | 1/8 | 1 | NM_153207.5 | ENSP00000266508 | ||
AEBP2 | ENST00000398864.7 | c.112G>A | p.Glu38Lys | missense_variant | 1/9 | 1 | ENSP00000381840 | P1 | ||
AEBP2 | ENST00000538425.5 | c.-16-22699G>A | intron_variant | 4 | ENSP00000444255 | |||||
AEBP2 | ENST00000541908.5 | c.-16-22699G>A | intron_variant | 3 | ENSP00000437983 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151952Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000301 AC: 3AN: 99712Hom.: 0 AF XY: 0.0000178 AC XY: 1AN XY: 56026
GnomAD4 exome AF: 0.0000471 AC: 64AN: 1358260Hom.: 1 Cov.: 36 AF XY: 0.0000478 AC XY: 32AN XY: 670024
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151952Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74212
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2021 | The c.112G>A (p.E38K) alteration is located in exon 1 (coding exon 1) of the AEBP2 gene. This alteration results from a G to A substitution at nucleotide position 112, causing the glutamic acid (E) at amino acid position 38 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at